Skip to Main Content

Paper Details

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions.
Blood Adv
3
2023
17, 53 genes, MDS, cytopenia, cytopenic conditions, genes, myelodysplastic syndromes, myeloid, myeloid malignancies, myeloid malignancy, non-MDS myeloid malignancy, patients, targeted gene, variant allele
Author NameAffiliation
Johannes B Goll
Robert Coleman LindsleyDana-Farber Cancer Institute
Rafael BejarMoores Cancer Center
Robert S FultonMcDonnell Genome Institute, Washington University School of Medicine
Robert S FultonMcDonnell Genome Institute, Washington University School of Medicine
Matthew J WalterWashington University School of Medicine
  • 1 - 6

Datasets

Release 1.2